Citadel Advisors’s Invacare Corporation IVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,400
Closed -$33K 14069
2022
Q2
$33K Buy
+25,400
New +$33.5K ﹤0.01% 12172
2021
Q4
Sell
-60,000
Closed -$286K 15213
2021
Q3
$286K Buy
+60,000
New +$438K ﹤0.01% 11150
2020
Q4
Sell
-12,300
Closed -$92K 11733
2020
Q3
$92K Sell
12,300
-7,900
-39% -$54.8K ﹤0.01% 9315
2020
Q2
$129K Buy
+20,200
New +$135K ﹤0.01% 8847
2019
Q4
Sell
-15,700
Closed -$118K 9982
2019
Q3
$118K Buy
15,700
+4,200
+37% +$23.6K ﹤0.01% 8409
2019
Q2
$60K Buy
+11,500
New +$75K ﹤0.01% 8672

Other funds holding IVC

Citadel Advisors's IVC Position: Q3 2022 in Review

Citadel Advisors sold out of Invacare Corporation (IVC) in Q3 2022, closing a stake of 128,707 shares — an estimated $135K sold.

Citadel Advisors first reported a position in IVC in Q2 2013 and held it in 31 quarters. The position peaked at $4.21M in Q2 2018. 72 funds tracked by Wall St. Rank hold IVC as of Q3 2022.

  • Citadel Advisors reported no remaining Invacare Corporation position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 128,707 Invacare Corporation shares in Q3 2022, an estimated $135K.
  • Citadel Advisors first reported a position in Invacare Corporation in Q2 2013 and held it in 31 quarters.
  • Citadel Advisors's Invacare Corporation position peaked at $4.21M in Q2 2018.
  • 72 funds tracked by Wall St. Rank held Invacare Corporation as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.